In this work, we further explored this mechanism by using another tau construct that includes the sequence that forms the core of Alzheimer’s disease tau filaments in vivo to obtain a distinct fibril type. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.